MARKET

BDTX

BDTX

Black Diamond Therapeutics, Inc.
NASDAQ
2.830
-0.110
-3.74%
After Hours: 2.860 +0.03 +1.06% 17:45 05/12 EDT
OPEN
2.930
PREV CLOSE
2.940
HIGH
2.931
LOW
2.730
VOLUME
662.13K
TURNOVER
--
52 WEEK HIGH
4.940
52 WEEK LOW
1.680
MARKET CAP
162.16M
P/E (TTM)
-3.7335
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDTX last week (0504-0508)?
Weekly Report · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), 20/20 Biolabs, Inc. (AIDX)
TipRanks · 4d ago
Wedbush Reaffirms Their Buy Rating on Black Diamond Therapeutics (BDTX)
TipRanks · 4d ago
Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028
TipRanks · 4d ago
Best Small Cap Value Stocks May 2026
Seeking Alpha · 5d ago
Black Diamond Therapeutic Q1 EPS $(0.16) Misses $(0.03) Estimate
Benzinga · 5d ago
Black Diamond Therapeutics GAAP EPS of -$0.16 beats by $0.02
Seeking Alpha · 5d ago
BLACK DIAMOND THERAPEUTICS: Q1 EPS $-0.16
Reuters · 5d ago
More
About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The Company is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. Its BDTX-4933 pipeline product is out-licensed to Servier. BDTX-4933 is designed to target RAS and RAF alterations in solid tumors. It is exploring partnership opportunities for its FGFR2/3 selective development candidate BDTX-4876.

Webull offers Black Diamond Therapeutics Inc stock information, including NASDAQ: BDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDTX stock methods without spending real money on the virtual paper trading platform.